AstraZeneca shares rose 7% after the company reported its quarterly results. The drugmaker beat earnings forecasts. It also launched a $1.5 billion savings plan to fund its AI-backed research pipeline.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
